Jane Street
AMAM

Jane Street’s Ambrx Biopharma Inc AMAM Stock Holding History

Jane Street’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-295,642
Closed -$4.21M – 10376
2023
Q4 		$4.21M Buy
+295,642
New +$3.36M ﹤0.01% 3102
2023
Q3 		– Sell
-17,538
Closed -$239K – 9613
2023
Q2 		$289K Buy
+17,538
New +$221K ﹤0.01% 7191

Jane Street's AMAM Position: Q1 2024 in Review

Jane Street sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 295,642 shares — an estimated $4.21M sold.

Jane Street first reported a position in AMAM in Q2 2023 and held it in 2 quarters. The position peaked at $4.21M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Jane Street reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 295,642 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4.21M.
  • Jane Street first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 2 quarters.
  • Jane Street's Ambrx Biopharma Inc position peaked at $4.21M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.